journal article·2022-04-26

Investigating the Biological Effect of Multidimensional Ti3C2 (MXene)-Based Nanomaterials through a Metabolomics Approach: a Multidimensional-Determined Alteration in Energy Metabolism

Dingkun Zhang, Xin Li, Wen Zheng, Luolan Gui, Yin Yang, Ang Li, Yueqiu Liu, Tao Li, Cheng Deng, Jingping Liu, Jingqiu Cheng, Hao Yang, Meng Gong

Chemistry of Materials· Volume 34· Issue 8
Publisher page

Abstract

Multidimensional Ti3C2 (MXene)-based nanomaterials (m-MBNs, including nanosheets and quantum dots (QDs)) are vitally important transition-metal carbides or carbonitrides with dramatic photothermal activity in cancer therapy in animal models and display potential prospects for practical application. However, detailed bioinformation on multidimensional-induced variations in biocompatibility, metabolic processes, and mechanisms is insufficient. Metabolomics profiling has provided a distinguished alternative with massive bioinformation, which has shed light on the biological response of an organism under exogenous stimuli at the molecular level. In this work, m-MBNs were selected to interact with human umbilical vein endothelial cells (HUVECs), among which a metabolomics approach was applied to explore the changes in the HUVECs metabolome. The spatial distribution of metabolites was screened by desorption electrospray ionization-mass spectrometry imaging (DESI-MSI). The results revealed that nonobvious acute cytotoxicity was observed by cell proliferation and apoptosis assays. Comparatively, m-MBNs induced changes in the energy metabolism-related cellular events of HUVECs, while MXene QDs induced significant variation in cell metabolism, which was correlated with the multidimensional-determined mitochondria dysfunction. This work has the potential to evaluate metabolomic changes as a result of exposure to m-MBNs for assessing the biological effect of nanomaterials at the micro level. Moreover, such metabolomics-based profiling could also provide a biological forward expectation of these nanomaterials in future biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MXene and MAX Phase Materials · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Clinical Proteomics and Metabolomics, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China

Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu 610041, China

Laboratory of Mitochondrial and Metabolism, Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China

Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China

Funding

Sichuan University · Department of Science and Technology of Sichuan Province · Sichuan Science and Technology Program

References (59)

Show source-provided references
1. 10.1021/acsnano.1c0024810.1021/acsnano.1c00248 ↗
2. 10.1002/adfm.20200063710.1002/adfm.202000637 ↗
3. 10.1039/D0TA01552K10.1039/D0TA01552K ↗
4. 10.1039/C7NR05997C10.1039/C7NR05997C ↗
5. 10.1007/s00604-018-3220-910.1007/s00604-018-3220-9 ↗
6. 10.1016/j.matlet.2018.06.06310.1016/j.matlet.2018.06.063 ↗
7. 10.1002/adma.20160484710.1002/adma.201604847 ↗
8. 10.1002/jat.408510.1002/jat.4085 ↗
9. 10.1016/j.matdes.2020.10909110.1016/j.matdes.2020.109091 ↗
10. 10.1016/j.cej.2020.12600910.1016/j.cej.2020.126009 ↗
11. 10.1039/C7EN01239J10.1039/C7EN01239J ↗
12. 10.1002/jat.408510.1002/jat.4085 ↗
13. 10.1016/j.jhazmat.2017.06.00410.1016/j.jhazmat.2017.06.004 ↗
14. 10.1126/science.aaz646510.1126/science.aaz6465 ↗
15. 10.1038/s41580-019-0108-410.1038/s41580-019-0108-4 ↗
16. 10.1038/s41467-019-10900-y10.1038/s41467-019-10900-y ↗
17. 10.1038/nrneph.2017.3010.1038/nrneph.2017.30 ↗
18. 10.1016/j.cmet.2016.09.01810.1016/j.cmet.2016.09.018 ↗
19. 10.1038/nrd.2016.3210.1038/nrd.2016.32 ↗
20. 10.1016/j.trac.2010.11.00310.1016/j.trac.2010.11.003 ↗
21. 10.1021/cr300484s10.1021/cr300484s ↗
22. 10.1038/nrurol.2017.4610.1038/nrurol.2017.46 ↗
23. 10.1073/pnas.170067711410.1073/pnas.1700677114 ↗
24. 10.1002/jat.347010.1002/jat.3470 ↗
25. 10.1039/C8TB00754C10.1039/C8TB00754C ↗
26. 10.1016/j.carbon.2021.04.02310.1016/j.carbon.2021.04.023 ↗
27. 10.1002/aenm.20190021910.1002/aenm.201900219 ↗
28. 10.1021/acsami.9b1498510.1021/acsami.9b14985 ↗
29. 10.1039/C8NR03903H10.1039/C8NR03903H ↗
30. 10.1002/ange.20180223210.1002/ange.201802232 ↗
31. 10.1021/acsami.8b0831410.1021/acsami.8b08314 ↗
32. 10.1002/anie.20180871410.1002/anie.201808714 ↗
33. 10.1039/C9NR00084D10.1039/C9NR00084D ↗
34. 10.1039/C9NR05797H10.1039/C9NR05797H ↗
35. 10.1088/2053-1583/ab6a6010.1088/2053-1583/ab6a60 ↗
36. 10.1016/j.carbon.2021.04.02310.1016/j.carbon.2021.04.023 ↗
37. 10.20964/2017.03.0610.20964/2017.03.06 ↗
38. 10.1038/s41929-018-0195-110.1038/s41929-018-0195-1 ↗
39. 10.1002/jor.2413010.1002/jor.24130 ↗
40. 10.1002/jat.280810.1002/jat.2808 ↗
41. 10.1016/j.jhazmat.2021.12523410.1016/j.jhazmat.2021.125234 ↗
42. 10.1021/nn301113f10.1021/nn301113f ↗
43. 10.1146/annurev-immunol-081619-10485010.1146/annurev-immunol-081619-104850 ↗
44. 10.1016/j.cell.2020.07.03910.1016/j.cell.2020.07.039 ↗
45. 10.1007/s11064-019-02829-x10.1007/s11064-019-02829-x ↗
46. 10.1089/rej.2008.080710.1089/rej.2008.0807 ↗
47. 10.1007/s00232-020-00133-210.1007/s00232-020-00133-2 ↗
48. 10.1016/j.biortech.2019.12141410.1016/j.biortech.2019.121414 ↗
49. 10.1080/17435390.2018.143277910.1080/17435390.2018.1432779 ↗
50. 10.1039/C7CC02041D10.1039/C7CC02041D ↗
51. 10.1016/j.jinorgbio.2019.11079510.1016/j.jinorgbio.2019.110795 ↗
52. 10.1039/C7CP03724D10.1039/C7CP03724D ↗
53. 10.1016/j.talanta.2018.11.09210.1016/j.talanta.2018.11.092 ↗
54. 10.1021/jacs.1c0238310.1021/jacs.1c02383 ↗
55. 10.1007/s00299-021-02717-110.1007/s00299-021-02717-1 ↗
56. 10.4161/rdis.2404810.4161/rdis.24048 ↗
57. 10.1002/adfm.20210564910.1002/adfm.202105649 ↗
58. 10.1038/s41565-021-00924-110.1038/s41565-021-00924-1 ↗
59. 10.3791/6176010.3791/61760 ↗